About Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.

At the moment the company generates 3M USD in revenues.

On its last earning announcement, the company reported a loss of -1.54$ per share.

The book value per share is -0.23$

Outlook Therapeutics, Inc. website

Create a solid portfolio with OTLK

Add OTLK to your portfolio and optimize it!


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
3M - -36M - -37M -1.54 - - 13M -0.23 -35M -2M -36M